A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications

by Sangita M. Baxi, Reed Beall, Joshua Yang, Tim K. Mackey
Published 2019-09-01

miR-221 promotes tumorigenesis in human triple negative breast cancer cells.

by Rounak Nassirpour, Pramod P Mehta, Sangita M Baxi, Min-Jean Yin
Published 2013-01-01

Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells.

by Sangita M Baxi, Wei Tan, Sean T Murphy, Tod Smeal, Min-Jean Yin
Published 2012-01-01